IN2014MN01384A - - Google Patents
Info
- Publication number
- IN2014MN01384A IN2014MN01384A IN1384MUN2014A IN2014MN01384A IN 2014MN01384 A IN2014MN01384 A IN 2014MN01384A IN 1384MUN2014 A IN1384MUN2014 A IN 1384MUN2014A IN 2014MN01384 A IN2014MN01384 A IN 2014MN01384A
- Authority
- IN
- India
- Prior art keywords
- amino acids
- hiv
- fusion
- inhibitor
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11194340 | 2011-12-19 | ||
PCT/EP2012/075956 WO2013092591A1 (en) | 2011-12-19 | 2012-12-18 | Hiv membrane fusion inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN01384A true IN2014MN01384A (es) | 2015-04-03 |
Family
ID=47501221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1384MUN2014 IN2014MN01384A (es) | 2011-12-19 | 2012-12-18 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20140357577A1 (es) |
EP (1) | EP2794636A1 (es) |
JP (1) | JP2015502378A (es) |
CN (1) | CN104159914A (es) |
BR (1) | BR112014014917A2 (es) |
IN (1) | IN2014MN01384A (es) |
RU (1) | RU2014129907A (es) |
WO (1) | WO2013092591A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013163567A2 (en) * | 2012-04-27 | 2013-10-31 | The Trustees Of The University Of Pennsylvania | Novel alpha-helical peptidomimetic inhibitors and methods using same |
CN109320593A (zh) * | 2018-11-05 | 2019-02-12 | 中国人民解放军军事科学院军事医学研究院 | 抑制hiv感染的螺旋多肽及其用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6339069B1 (en) * | 1996-10-15 | 2002-01-15 | Elan Pharmaceuticalstechnologies, Inc. | Peptide-lipid conjugates, liposomes and lipsomal drug delivery |
EP1452868A2 (en) | 2003-02-27 | 2004-09-01 | Pepscan Systems B.V. | Method for selecting a candidate drug compound |
US20080025977A1 (en) * | 2003-04-14 | 2008-01-31 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of CD59 |
RU2006128593A (ru) * | 2004-01-07 | 2008-02-20 | Тримерис, Инк. (Us) | Синтетические пептиды, производные области hr2 белка gp41 вич, и их применение в терапии для ингибирования проникновения вируса иммунодефицита человека |
NZ560504A (en) * | 2005-01-24 | 2009-07-31 | Pepscan Systems Bv | Binding compounds, immunogenic compounds and peptidomimetics |
CA2651793C (en) * | 2006-02-02 | 2015-07-07 | Trimeris, Inc. | Hiv fusion inhibitor peptides with improved biological properties |
US20080131428A1 (en) * | 2006-02-24 | 2008-06-05 | Arius Research, Inc. | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
US20090082276A1 (en) * | 2006-02-28 | 2009-03-26 | Lianshan Zhang | Selective vpac2 receptor peptide agonists |
US20090142336A1 (en) * | 2006-02-28 | 2009-06-04 | Trustees Of Boston University | Metabolic regulators and uses thereof |
GB0720503D0 (en) * | 2007-10-22 | 2007-11-28 | Angeletti P Ist Richerche Bio | New compound |
-
2012
- 2012-12-18 RU RU2014129907A patent/RU2014129907A/ru not_active Application Discontinuation
- 2012-12-18 EP EP12809772.2A patent/EP2794636A1/en not_active Withdrawn
- 2012-12-18 IN IN1384MUN2014 patent/IN2014MN01384A/en unknown
- 2012-12-18 BR BR112014014917A patent/BR112014014917A2/pt not_active IP Right Cessation
- 2012-12-18 JP JP2014547930A patent/JP2015502378A/ja active Pending
- 2012-12-18 WO PCT/EP2012/075956 patent/WO2013092591A1/en active Application Filing
- 2012-12-18 US US14/367,197 patent/US20140357577A1/en not_active Abandoned
- 2012-12-18 CN CN201280062599.0A patent/CN104159914A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20140357577A1 (en) | 2014-12-04 |
CN104159914A (zh) | 2014-11-19 |
RU2014129907A (ru) | 2016-02-10 |
WO2013092591A1 (en) | 2013-06-27 |
EP2794636A1 (en) | 2014-10-29 |
JP2015502378A (ja) | 2015-01-22 |
BR112014014917A2 (pt) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125155T1 (el) | Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης | |
MD4589C1 (ro) | Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C | |
MX358224B (es) | Composicion farmaceutica para el tratamiento y/o prevencion de cancer de higado. | |
CO6811816A2 (es) | Composiciones que contienen, métodos que involucran, y usos de derivados de dolastatina unidos a aminiácidos no naturales | |
PE20141906A1 (es) | Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento | |
PH12015501156A1 (en) | Pharmaceutical compositions | |
BR112015013525A2 (pt) | método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão | |
ECSP13012534A (es) | Composición farmacéutica | |
MX2012009581A (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
EP3363458A3 (en) | A peptide | |
WO2011036564A3 (en) | Hyperblebbing shigella strains | |
ES2666720T3 (es) | Composición para prevenir o tratar el cáncer de cuello uterino con un potenciador de la inmunidad contra el virus de papiloma humano | |
IL231421A (en) | Lupane and its similar compounds are preserved in position 3ß by carboxy-alkyl-carbonyl-oxy and position 17- by (alkyl-conserved) amino, and also anti-HIV drug preparations containing them | |
CA2864145A1 (en) | Autophagy-inducing peptide | |
IN2014CN00572A (es) | ||
WO2012047267A3 (en) | Polyvalent immunogen | |
HK1200329A1 (en) | Truncated hiv envelope proteins (env), methods and compositions related thereto hiv (env) | |
EA201300733A1 (ru) | Рекомбинантные микобактерии в качестве вакцины | |
AR090073A1 (es) | N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos | |
IN2014MN01384A (es) | ||
WO2012115903A3 (en) | Yeast strain for the production of proteins with modified o-glycosylation | |
NZ717192A (en) | Anti-inflammatory tripeptides | |
MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
MX2014006574A (es) | Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas. | |
BR112012027753A2 (pt) | preparação de polipeptídeos e sais dos mesmos |